Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD Jul 12, 2021
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Charting Its Own Course in Psychedelic Space Jun 30, 2021
COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health” Jun 30, 2021
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb… Jun 28, 2021
Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004 Jun 24, 2021
MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer’s disease and related forms of Dementia with… Jun 23, 2021
